Soluble urokinase plasminogen activator receptor (suPAR) is a potential biomarker of stage III-IV, grade C periodontitis through the impact of post-radiotherapy on head and neck cancer patients
Abstract Background The urokinase-type plasminogen activator receptor (uPAR) plays an essential function in leukocytes and endothelial homeostasis and, therefore, in the development of chronic periodontitis. Methods The study enrolled 150 participants, 50 chronic periodontitis with head and neck can...
Saved in:
Main Authors: | Ahmed A. Al-Kubaisi (Author), Maysam Abdulrahman Ghazi (Author), Nisreen Salah Majeed (Author), Ekram R. Aldelaimi (Author), Hamid H. Enezei (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2024-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Soluble urokinase plasminogen activator receptor (suPAR) in the emergency department: An update
by: Dimitrios Velissaris, et al.
Published: (2022) -
Soluble Urokinase Plasminogen Activator Receptor (SuPAR) Analysis for Diagnosis of Periprosthetic Joint Infection
by: Sebastian M. Klim, et al.
Published: (2024) -
Soluble urokinase plasminogen activator receptor (suPAR) and glomerular disease in children: a narrative review
by: Phuong Anh Le Thy, et al.
Published: (2022) -
Point-of-care prognostication in moderate Covid-19: Analytical validation and prognostic accuracy of a soluble urokinase plasminogen activator receptor (suPAR) rapid test.
by: Arjun Chandna, et al.
Published: (2023) -
Point-of-care prognostication in moderate Covid-19: Analytical validation and prognostic accuracy of a soluble urokinase plasminogen activator receptor (suPAR) rapid test
by: Arjun Chandna, et al.
Published: (2023)